Albert David Limited
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Albert David Limited - Asset Resilience Ratio
Albert David Limited (ALBERTDAVD) has an Asset Resilience Ratio of 53.18% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2025)
This chart shows how Albert David Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Albert David Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹243.10 Million | 4.56% |
| Short-term Investments | ₹2.59 Billion | 48.61% |
| Total Liquid Assets | ₹2.83 Billion | 53.18% |
Asset Resilience Insights
- Very High Liquidity: Albert David Limited maintains exceptional liquid asset reserves at 53.18% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Albert David Limited Industry Peers by Asset Resilience Ratio
Compare Albert David Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Albert David Limited (2006–2025)
The table below shows the annual Asset Resilience Ratio data for Albert David Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 47.36% | ₹2.42 Billion | ₹5.11 Billion | -8.82pp |
| 2024-03-31 | 56.18% | ₹2.80 Billion | ₹4.98 Billion | +5.62pp |
| 2023-03-31 | 50.56% | ₹2.14 Billion | ₹4.23 Billion | +3.69pp |
| 2022-03-31 | 46.87% | ₹1.89 Billion | ₹4.03 Billion | +4.16pp |
| 2021-03-31 | 42.71% | ₹1.46 Billion | ₹3.41 Billion | +12.23pp |
| 2020-03-31 | 30.48% | ₹976.08 Million | ₹3.20 Billion | -0.51pp |
| 2019-03-31 | 30.99% | ₹915.50 Million | ₹2.95 Billion | +5.18pp |
| 2018-03-31 | 25.81% | ₹746.42 Million | ₹2.89 Billion | +3.99pp |
| 2017-03-31 | 21.82% | ₹537.86 Million | ₹2.46 Billion | +5.87pp |
| 2016-03-31 | 15.95% | ₹357.01 Million | ₹2.24 Billion | +17.69pp |
| 2015-03-31 | -1.74% | ₹-33.69 Million | ₹1.93 Billion | -2.13pp |
| 2007-03-31 | 0.39% | ₹5.60 Million | ₹1.44 Billion | -0.29pp |
| 2006-03-31 | 0.68% | ₹6.20 Million | ₹912.38 Million | -- |